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ABSTRACT 
 
Background: Meningiomas are tumors that arise from the lepto meningeal covering of brain and spinal cord, 
accounting for upto 34% of all CNS tumors. Mostly meningiomas are slow growing and are generally considered 
benign tumors. Meningiomas usually clinically evident in middle aged. Histopathological examination and grading 
of meningiomas give valuable prognostic information. Known risk factors for recurrence include histological 
malignancy grade, sub total resection, young age, specific sub types, brain infiltration and high proliferative rate. 
Aim: To study histopathological spectrum of meningiomas and its variants. Materials and methods: It is a 
Prospective study of  19 cases with meningiomas have been studied for a period of 1 year . Results  :.Most common 
age group  between 40-60-yrs .Male:Female -1:4. Out of 121 CNS lesions during the study period 19 cases were 
reported as  Meningiomas  which accounts for 17% of CNS lesions. Out of  19 cases, majority were benign  89.6%  ,   
Atypical 5.2%  and  Anaplastic 5.2% of meningiomas.Atypical meningiomas comprise between 4.7% and 7.2% of 
meningiomas,although using more current definition it has been reported in up to 20%.  Conclusion: Continuous 
revision of histopathological classification systems is required to improve the diagnostic accuracy. 
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Introduction 
 
Meningioma comprises about one fourth of all primary 
tumors of the central nervous system (CNS). It is the 
most common primary intracranial neoplasm and the 
most diversified in histologic patterns among all 
primary tumors of the CNS. Meningiomas, as defined 
by the World Health Organization (WHO), are 
"meningothelial (arachnoid) cell neoplasms, typically 
attached to the inner surface of the dura mater," and 
these tumors fall into WHO grades I, II, and III. In 
clinical practice, however, the diagnosis is based on 
light microscopy of routinely stained Haematoxylin & 
Eosin sections with criteria given by World Health 
Organization (WHO)[1]. This classification scheme  
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provides guidelines for tumour grading and subtypes. 
Meningiomas (benign) are recognised by their 
histologic subtype and lack of anaplastic features. 
Grade II meningiomas (atypical) are defined by one or 
more of the following four criteria: 1) chordoid or clear 
cell histologic subtype, 2) four to 19 mitoses per ten 
high-power field (HPFs), 3) brain infiltration, and 4) 
three or more of the following five histologic features: 
small cell change, increased cellularity, prominent 
nucleoli, sheet-like growth, or necrosis. Grade III 
meningiomas (anaplastic/malignant) are defined by 
rhabdoid or papillary subtypes, a histological picture of 
frank malignancy resembling that of carcinomas, 
melanomas, or high grade sarcomas, or 20 or more 
mitosis per ten HPFs[2].The histologic patterns and 
biologic spectrum of meningiomas partially reflect the 
aforementioned biologic functions and embryogenesis. 
Both non-neoplastic meningothelial cells and 
meningiomas possess mixed features of epithelial and 
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mesenchymal cells. In meningiomas, one feature may 
be dominant over the other, and this phenomenon 
partly contributes to the rich diversification of 
histologic patterns in these tumorshe only change 
between the WHO 2007 and 2000 edition is that brain-
infiltrative and otherwise benign meningiomas are 
classified as grade II [4]. Our aim of study is  the 
incidence of  Menigiomas  and various 
Histomorphological variants in meningiomas . 
Materials and methods 
It is a Prospective study for a duration of  1 year  from  
August 2013  - July2014. Specimens received in 
department of Pathology,MIMS are immediately fixed 
in 10%buffered formalin. Specimens less than 2 cm are 
all embedded. All the specimens are subjected to 
routine processing.  
Results 
Table 1: Age Distribution 
Age group (yrs)  NO. OF CASES  %  
1 - 10  --  --  
11-20  
  
21-30  1  5.2  
31-40  3  15.7  
41-50  6  31.5  
51-60  5  26.3  
61-70  2  10.5  
71-80  2  10.5  
Total 19 99.9  
 
Table 2: Sex Distribution 
Sex  No.Of Cases   Percentage  
Male 06 31.5% 
Female 13 68.4% 
Total 19 99.9% 
 
Table 3:Histomorphological Patterns of  Meningiomas 
Variants  No.Of Cases   Percentage  
Meningotheliomatous meninigioma  08 42.1% 
Psamomatous  meninigioma  05 26.3  % 
Transitional meninigioma  02 10.5% 
Angiobastic meninigioma  01 5.2% 
Fibroblastic meninigioma  01 5.2% 
Atypical meninigioma[Grade II]  01 5.2 % 
Papillary meningioma[Grade III]  01 5.2 % 
Total  19 100% 
 
Meningotheliomatous meninigioma  has highest incidence of 42.1% 
Histopathology slides in study 
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A)Meningotheliomatous Meningioma              B) Psammomatous Meningioma 
 
                                C)Fibroblastic Meningioma                               D) Angiomatous Meningioma 
 
 
                                                                      E)Atypical Meningioma  
Figure: A) This variant  shows arrangement of tumor cells in lobular nests, separated by collageneous septa. 
These cells are generally polygonal in shape with eosinophilic cytoplasm, nucleus is oval and is centrally 
placed. Prominent nucleoli. B)) This variant  shows “abundant Psammoma bodies”.C) This variant  shows 
proliferation of spindled meningothelial cells arranged in interlacing bundles. The nuclei tend to be narrow and rod-
shaped.D) This variant  shows numerous small or large vascular channels predominate over its meningothelial 
elements. E)This variant shows Increased cellularity  ,mitotic figures   N:C ratio, prominent nucleoli  
Discussion 
In the present  study 19 cases of meningiomas have 
been studied and classified according to the latest 
WHO classification of 2007,with the aim to study the 
incidence of  menigiomas  and  various 
histomorphological variants in meningiomas.  Most 
common age group  between 40-60-yrsMedian age at 
surgery did not diverge between different WHO 
tumour grades in accordance with the literature [5,6]. 
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We also confirmed the higher frequency of benign 
meningiomas in females compared to males, which 
may be explained by a progesterone-dependent tumour 
growth [7,8]. In addition, we recognized two peaks in 
the age-grouped distribution among female patients 
resembling a phenomenon named Clemmesen's hook. 
[9,10]Male:Female -1:4 with the higher frequency of 
benign meningiomas in females compared to males, 
which may be explained by a progesterone-dependent 
tumour growth [11].  
 
Table 4: Comparative  evaluation of Grade I Histological variants of the present study with other study 
Authors  Total 
cases  
Transitional Fibroblastic  Meningothelial  Pssamomatous  Age of 
presentation  
FF Cruz 
Sanchz  et 
al[ 12] 
41 3  8  19  0  40-60yrs  
Present 
Study  
    19       2  03  08  05  40-60yrs  
 
Out of total 19 cases, majority were benign(89.6%) 
meningiomas,  5.2% atypical  and 5.2% papillary 
meningioma . Increased fibrosis or widespread 
collagen formation are commonly seen in meningiomas 
regardless of tumour grade, and this is probably linked 
to the meningothelial cells’ proposed functions [13]. 
 Psammoma bodies have been found as a protective 
factor for recurrence [14]. Similarly, we found a trend 
for psammoma bodies to occur more frequently in 
benign tumours and without relation to other atypical 
features. The presence of lymphocytes, plasma cells, 
and macrophages in the meningioma tissue may reflect 
various immune responses against the tumour[12]. In 
addition, the meningothelial cap cells may also exhibit 
monocyte-like functions 
Table 5: Comparative Studies 
Variants  Thomas Baker et al [15] Present study  
Grade I, Benign  69.9% (135)  89.6%( 17)  
Grade II, Atypical  29.1% (59)  5.2%  ( 10)  
Grade III, Anaplastic     1%   ( 2)  5.2%   ( 1)  
Total no of cases     196  19  
 
In 2007 WHO classification all brain infiltrative specimens are classified as grade II(Atypical).In the present  study, 
cases with brain invasion were not reported. Whereas Thomas Backer et al[15]  reported 30% of the meningiomas as 
atypical. 
Conclusion 
Meningiomas are extremely common intracranial brain 
tumors originating from meningeal coverings of the 
brain and spinal cord. The histological appearance of  
meningioma is associated with the tumour's behaviour , 
which in turn affects prognosis. Since the behaviour of 
a tumour also determines the management ,grading 
also provides a guide for the management of the 
varying subtypes.Out of  121 CNS lesions during the 
study period 19 cases were  reported as  Meningiomas  
which accounts for 17% of CNS lesions. Out of  19 
cases, majority were benign  89.6%  ,   Atypical 5.2%  
and  Anaplastic 5.2% of meningiomas. Atypical 
meningiomas comprise between 4.7% and 7.2% of 
meningiomas,although using more current definition it 
has been reported in up to 20%. 
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